Industry Research Reports
Home > Reports > Medical Care > Global Competent Cells Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Global Competent Cells Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Industry: Medical Care
Published Date: 2024-04-17
Pages: 189 Pages
Report ld: 2695648
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Competent Cells Market Size(US$)
CAGR 2024-2030
9.5%
Market Size,2030
USD 3,782
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 2,194 million
Market Forecast in 2030(Value)
US$ 3,782 million
CAGR
9.5%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
The global Competent Cells market size was US$ 1989 million in 2023 and is forecast to a readjusted size of US$ 3782 million by 2030 with a CAGR of 9.5% during the forecast period 2024-2030. Fully considering the economic change by this health crisis, Chemically Competent Cells accounting for % of the Competent Cells global market in 2023, is projected to value US$ million by 2030, growing at a revised % CAGR from 2024 to 2030. While Subcloning & Routine Cloning segment is altered to an % CAGR throughout this forecast period.
Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.
North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.
In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Competent Cells market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Competent Cells market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Competent Cells market. Readers of the report can become informed about current and future trends of the global Competent Cells market and how they will impact market growth during the forecast period.
MARKET SEGMENTATION
By Company
- Merck KGaA
- Thermo Fisher Scientific
- Agilent Technologies
- Takara Bio
- Promega Corporation
- Beijing TransGen Biotech
- GeneScript Corporation
- Yeastern Biotech
- New England Biolabs
- QIAGEN N.V.
- OriGene Technologies
- Lucigen
- Zymo Research
- Bio-Rad Laboratories
- Bioline
- Delphi Genetics
- IBA GmBH
- Cell Applications
- BioDynamics Laboratory
- Scarab Genomics
- GCC Biotech
- SMOBIO Technology
- Edge BioSystems
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Chemically Competent Cells
- Electrocompetent Cells
Segment by Application
- Subcloning & Routine Cloning
- Phage Display Library Construction
- Toxic/Unstable DNA Cloning
- High-Throughput Cloning
- Protein Expression
- Mutagenesis
- Single-Stranded DNA Production
- Bacmid Creation
- Cre-Lox Recombination (PIR1/PIR2)
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Competent Cells in global and regional level.
Chapter 3: Detailed analysis of Competent Cells companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Competent Cells revenue, gross margin, and recent development, etc.
Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13: Research Findings and Conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Competent Cells Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemically Competent Cells
1.2.3 Electrocompetent Cells
1.3 Market by Application
1.3.1 Global Competent Cells Market Growth Rate by Application: 2019 VS 2023 VS 2030
1.3.2 Subcloning & Routine Cloning
1.3.3 Phage Display Library Construction
1.3.4 Toxic/Unstable DNA Cloning
1.3.5 High-Throughput Cloning
1.3.6 Protein Expression
1.3.7 Mutagenesis
1.3.8 Single-Stranded DNA Production
1.3.9 Bacmid Creation
1.3.10 Cre-Lox Recombination (PIR1/PIR2)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Competent Cells Market Size (2019-2030)
2.2 Competent Cells Market Size across Key Geographies Worldwide: 2019 VS 2023 VS 2030
2.3 Global Competent Cells Market Size by Region (2019-2024)
2.4 Global Competent Cells Market Size Forecast by Region (2025-2030)
2.5 Global Top 10 Competent Cells Countries Ranking by Market Size
3 Competent Cells Competitive by Company
3.1 Global Competent Cells Revenue by Players
3.1.1 Global Competent Cells Revenue by Players (2019-2024)
3.1.2 Global Competent Cells Market Share by Players (2019-2024)
3.2 Global Competent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Competent Cells Revenue
3.4 Global Competent Cells Market Concentration Ratio
3.4.1 Global Competent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Competent Cells Revenue in 2023
3.5 Global Key Players of Competent Cells Head office and Area Served
3.6 Global Key Players of Competent Cells, Product and Application
3.7 Global Key Players of Competent Cells, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Competent Cells Breakdown Data by Type
4.1 Global Competent Cells Historic Revenue by Type (2019-2024)
4.2 Global Competent Cells Forecasted Revenue by Type (2025-2030)
5 Global Competent Cells Breakdown Data by Application
5.1 Global Competent Cells Historic Market Size by Application (2019-2024)
5.2 Global Competent Cells Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Competent Cells Revenue by Company (2022-2024)
6.2 North America Competent Cells Revenue by Type (2019-2030)
6.3 North America Competent Cells Revenue by Application (2019-2030)
6.4 North America Competent Cells Revenue by Country (2019-2030)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Competent Cells Revenue by Company (2022-2024)
7.2 Europe Competent Cells Revenue by Type (2019-2030)
7.3 Europe Competent Cells Revenue by Application (2019-2030)
7.4 Europe Competent Cells Revenue by Country (2019-2030)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Competent Cells Revenue by Company (2022-2024)
8.2 Asia Pacific Competent Cells Revenue by Type (2019-2030)
8.3 Asia Pacific Competent Cells Revenue by Application (2019-2030)
8.4 Asia Pacific Competent Cells Revenue by Region (2019-2030)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Competent Cells Revenue by Company (2022-2024)
9.2 Latin America Competent Cells Revenue by Type (2019-2030)
9.3 Latin America Competent Cells Revenue by Application (2019-2030)
9.4 Latin America Competent Cells Revenue by Country (2019-2030)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Competent Cells Revenue by Company (2022-2024)
10.2 Middle East and Africa Competent Cells Revenue by Type (2019-2030)
10.3 Middle East and Africa Competent Cells Revenue by Application (2019-2030)
10.4 Middle East and Africa Competent Cells Revenue by Country (2019-2030)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Competent Cells Products and Services
11.1.4 Merck KGaA Competent Cells Revenue in Competent Cells Business (2019-2024)
11.1.5 Merck KGaA Competent Cells SWOT Analysis
11.1.6 Merck KGaA Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Competent Cells Products and Services
11.2.4 Thermo Fisher Scientific Competent Cells Revenue in Competent Cells Business (2019-2024)
11.2.5 Thermo Fisher Scientific Competent Cells SWOT Analysis
11.2.6 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Competent Cells Products and Services
11.3.4 Agilent Technologies Competent Cells Revenue in Competent Cells Business (2019-2024)
11.3.5 Agilent Technologies Competent Cells SWOT Analysis
11.3.6 Agilent Technologies Recent Development
11.4 Takara Bio
11.4.1 Takara Bio Company Details
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Competent Cells Products and Services
11.4.4 Takara Bio Competent Cells Revenue in Competent Cells Business (2019-2024)
11.4.5 Takara Bio Competent Cells SWOT Analysis
11.4.6 Takara Bio Recent Development
11.5 Promega Corporation
11.5.1 Promega Corporation Company Details
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Competent Cells Products and Services
11.5.4 Promega Corporation Competent Cells Revenue in Competent Cells Business (2019-2024)
11.5.5 Promega Corporation Competent Cells SWOT Analysis
11.5.6 Promega Corporation Recent Development
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Details
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Competent Cells Products and Services
11.6.4 Beijing TransGen Biotech Competent Cells Revenue in Competent Cells Business (2019-2024)
11.6.5 Beijing TransGen Biotech Competent Cells SWOT Analysis
11.6.6 Beijing TransGen Biotech Recent Development
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Details
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Competent Cells Products and Services
11.7.4 GeneScript Corporation Competent Cells Revenue in Competent Cells Business (2019-2024)
11.7.5 GeneScript Corporation Competent Cells SWOT Analysis
11.7.6 GeneScript Corporation Recent Development
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Details
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Competent Cells Products and Services
11.8.4 Yeastern Biotech Competent Cells Revenue in Competent Cells Business (2019-2024)
11.8.5 Yeastern Biotech Competent Cells SWOT Analysis
11.8.6 Yeastern Biotech Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Competent Cells Products and Services
11.9.4 New England Biolabs Competent Cells Revenue in Competent Cells Business (2019-2024)
11.9.5 New England Biolabs Competent Cells SWOT Analysis
11.9.6 New England Biolabs Recent Development
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Details
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Competent Cells Products and Services
11.10.4 QIAGEN N.V. Competent Cells Revenue in Competent Cells Business (2019-2024)
11.10.5 QIAGEN N.V. Competent Cells SWOT Analysis
11.10.6 QIAGEN N.V. Recent Development
11.11 OriGene Technologies
11.11.1 OriGene Technologies Company Details
11.11.2 OriGene Technologies Business Overview
11.11.3 OriGene Technologies Competent Cells Products and Services
11.11.4 OriGene Technologies Competent Cells Revenue in Competent Cells Business (2019-2024)
11.11.5 OriGene Technologies Recent Development
11.12 Lucigen
11.12.1 Lucigen Company Details
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Competent Cells Products and Services
11.12.4 Lucigen Competent Cells Revenue in Competent Cells Business (2019-2024)
11.12.5 Lucigen Recent Development
11.13 Zymo Research
11.13.1 Zymo Research Company Details
11.13.2 Zymo Research Business Overview
11.13.3 Zymo Research Competent Cells Products and Services
11.13.4 Zymo Research Competent Cells Revenue in Competent Cells Business (2019-2024)
11.13.5 Zymo Research Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Competent Cells Products and Services
11.14.4 Bio-Rad Laboratories Competent Cells Revenue in Competent Cells Business (2019-2024)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 Bioline
11.15.1 Bioline Company Details
11.15.2 Bioline Business Overview
11.15.3 Bioline Competent Cells Products and Services
11.15.4 Bioline Competent Cells Revenue in Competent Cells Business (2019-2024)
11.15.5 Bioline Recent Development
11.16 Delphi Genetics
11.16.1 Delphi Genetics Company Details
11.16.2 Delphi Genetics Business Overview
11.16.3 Delphi Genetics Competent Cells Products and Services
11.16.4 Delphi Genetics Competent Cells Revenue in Competent Cells Business (2019-2024)
11.16.5 Delphi Genetics Recent Development
11.17 IBA GmBH
11.17.1 IBA GmBH Company Details
11.17.2 IBA GmBH Business Overview
11.17.3 IBA GmBH Competent Cells Products and Services
11.17.4 IBA GmBH Competent Cells Revenue in Competent Cells Business (2019-2024)
11.17.5 IBA GmBH Recent Development
11.18 Cell Applications
11.18.1 Cell Applications Company Details
11.18.2 Cell Applications Business Overview
11.18.3 Cell Applications Competent Cells Products and Services
11.18.4 Cell Applications Competent Cells Revenue in Competent Cells Business (2019-2024)
11.18.5 Cell Applications Recent Development
11.19 BioDynamics Laboratory
11.19.1 BioDynamics Laboratory Company Details
11.19.2 BioDynamics Laboratory Business Overview
11.19.3 BioDynamics Laboratory Competent Cells Products and Services
11.19.4 BioDynamics Laboratory Competent Cells Revenue in Competent Cells Business (2019-2024)
11.19.5 BioDynamics Laboratory Recent Development
11.20 Scarab Genomics
11.20.1 Scarab Genomics Company Details
11.20.2 Scarab Genomics Business Overview
11.20.3 Scarab Genomics Competent Cells Products and Services
11.20.4 Scarab Genomics Competent Cells Revenue in Competent Cells Business (2019-2024)
11.20.5 Scarab Genomics Recent Development
11.21 GCC Biotech
11.21.1 GCC Biotech Company Details
11.21.2 GCC Biotech Business Overview
11.21.3 GCC Biotech Competent Cells Products and Services
11.21.4 GCC Biotech Competent Cells Revenue in Competent Cells Business (2019-2024)
11.21.5 GCC Biotech Recent Development
11.22 SMOBIO Technology
11.22.1 SMOBIO Technology Company Details
11.22.2 SMOBIO Technology Business Overview
11.22.3 SMOBIO Technology Competent Cells Products and Services
11.22.4 SMOBIO Technology Competent Cells Revenue in Competent Cells Business (2019-2024)
11.22.5 SMOBIO Technology Recent Development
11.23 Edge BioSystems
11.23.1 Edge BioSystems Company Details
11.23.2 Edge BioSystems Business Overview
11.23.3 Edge BioSystems Competent Cells Products and Services
11.23.4 Edge BioSystems Competent Cells Revenue in Competent Cells Business (2019-2024)
11.23.5 Edge BioSystems Recent Development
12 Competent Cells Market Dynamics
12.1 Competent Cells Industry Trends
12.2 Competent Cells Market Drivers
12.3 Competent Cells Market Challenges
12.4 Competent Cells Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Competent Cells Market Size Growth Rate (CAGR) by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Chemically Competent Cells
Table 3. Key Players of Electrocompetent Cells
Table 4. Global Competent Cells Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Competent Cells Market Size (US$ Million) Growth Rate (CAGR) by Region: 2019 VS 2023 VS 2030
Table 6. Global Competent Cells Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Competent Cells Revenue Forecast by Region (2025-2030) & (US$ Million)
Table 8. Global Competent Cells Market Size of Top 10 Countries, 2019 VS 2023 VS 2030, (US$ Million)
Table 9. Global Competent Cells Revenue by Players (2019-2024) & (US$ Million)
Table 10. Global Competent Cells Market Share by Players (2019-2024)
Table 11. Global Top Competent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Competent Cells as of 2023)
Table 12. Ranking of Global Top Competent Cells Companies by Revenue (US$ Million) in 2023
Table 13. Global 5 Largest Players Market Share by Competent Cells Revenue (CR5 and HHI) & (2019-2024)
Table 14. Global Key Players of Competent Cells, Headquarters and Area Served
Table 15. Global Key Players of Competent Cells, Product and Application
Table 16. Global Key Players of Competent Cells, Date of Enter into This Industry
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Competent Cells Market Size by Type (2019-2024) & (US$ Million)
Table 19. Global Competent Cells Revenue Market Share by Type (2019-2024)
Table 20. Global Competent Cells Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 21. Global Competent Cells Revenue Market Share by Type (2025-2030)
Table 22. Global Competent Cells Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Competent Cells Revenue Market Share by Application (2019-2024)
Table 24. Global Competent Cells Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 25. Global Competent Cells Revenue Market Share by Application (2025-2030)
Table 26. North America Competent Cells Revenue by Company (2022-2024) & (US$ Million)
Table 27. North America Competent Cells Revenue by Type (2019-2024) & (US$ Million)
Table 28. North America Competent Cells Revenue by Type (2025-2030) & (US$ Million)
Table 29. North America Competent Cells Revenue by Application (2019-2024) & (US$ Million)
Table 30. North America Competent Cells Revenue by Application (2025-2030) & (US$ Million)
Table 31. North America Competent Cells Revenue Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Competent Cells Revenue by Country (2019-2024) & (US$ Million)
Table 33. North America Competent Cells Revenue by Country (2025-2030) & (US$ Million)
Table 34. Europe Competent Cells Revenue by Company (2022-2024) & (US$ Million)
Table 35. Europe Competent Cells Revenue by Type (2019-2024) & (US$ Million)
Table 36. Europe Competent Cells Revenue by Type (2025-2030) & (US$ Million)
Table 37. Europe Competent Cells Revenue by Application (2019-2024) & (US$ Million)
Table 38. Europe Competent Cells Revenue by Application (2025-2030) & (US$ Million)
Table 39. Europe Competent Cells Revenue Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Competent Cells Revenue by Country (2019-2024) & (US$ Million)
Table 41. Europe Competent Cells Revenue by Country (2025-2030) & (US$ Million)
Table 42. Asia Pacific Competent Cells Revenue by Company (2022-2024) & (US$ Million)
Table 43. Asia Pacific Competent Cells Revenue by Type (2019-2024) & (US$ Million)
Table 44. Asia Pacific Competent Cells Revenue by Type (2025-2030) & (US$ Million)
Table 45. Asia Pacific Competent Cells Revenue by Application (2019-2024) & (US$ Million)
Table 46. Asia Pacific Competent Cells Revenue by Application (2025-2030) & (US$ Million)
Table 47. Asia-Pacific Competent Cells Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 48. Asia Pacific Competent Cells Revenue by Region (2019-2024) & (US$ Million)
Table 49. Asia Pacific Competent Cells Revenue by Region (2025-2030) & (US$ Million)
Table 50. Latin America Competent Cells Revenue by Company (2022-2024) & (US$ Million)
Table 51. Latin America Competent Cells Revenue by Type (2019-2024) & (US$ Million)
Table 52. Latin America Competent Cells Revenue by Type (2025-2030) & (US$ Million)
Table 53. Latin America Competent Cells Revenue by Application (2019-2024) & (US$ Million)
Table 54. Latin America Competent Cells Revenue by Application (2025-2030) & (US$ Million)
Table 55. Latin America Competent Cells Revenue Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 56. Latin America Competent Cells Revenue by Country (2019-2024) & (US$ Million)
Table 57. Latin America Competent Cells Revenue by Country (2025-2030) & (US$ Million)
Table 58. Middle East and Africa Competent Cells Revenue by Company (2022-2024) & (US$ Million)
Table 59. Middle East and Africa Competent Cells Revenue by Type (2019-2024) & (US$ Million)
Table 60. Middle East and Africa Competent Cells Revenue by Type (2025-2030) & (US$ Million)
Table 61. Middle East and Africa Competent Cells Revenue by Application (2019-2024) & (US$ Million)
Table 62. Middle East and Africa Competent Cells Revenue by Application (2025-2030) & (US$ Million)
Table 63. Middle East and Africa Competent Cells Revenue Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 64. Middle East and Africa Competent Cells Revenue by Country (2019-2024) & (US$ Million)
Table 65. Middle East and Africa Competent Cells Revenue by Country (2025-2030) & (US$ Million)
Table 66. Merck KGaA Company Details
Table 67. Merck KGaA Business Overview
Table 68. Merck KGaA Competent Cells Product and Services
Table 69. Merck KGaA Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 70. Merck KGaA Competent Cells SWOT Analysis
Table 71. Merck KGaA Recent Development
Table 72. Thermo Fisher Scientific Company Details
Table 73. Thermo Fisher Scientific Business Overview
Table 74. Thermo Fisher Scientific Competent Cells Product and Services
Table 75. Thermo Fisher Scientific Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 76. Thermo Fisher Scientific Competent Cells SWOT Analysis
Table 77. Thermo Fisher Scientific Recent Development
Table 78. Agilent Technologies Company Details
Table 79. Agilent Technologies Business Overview
Table 80. Agilent Technologies Competent Cells Product and Services
Table 81. Agilent Technologies Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 82. Agilent Technologies Competent Cells SWOT Analysis
Table 83. Agilent Technologies Recent Development
Table 84. Takara Bio Company Details
Table 85. Takara Bio Business Overview
Table 86. Takara Bio Competent Cells Product and Services
Table 87. Takara Bio Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 88. Takara Bio Competent Cells SWOT Analysis
Table 89. Takara Bio Recent Development
Table 90. Promega Corporation Company Details
Table 91. Promega Corporation Business Overview
Table 92. Promega Corporation Competent Cells Product and Services
Table 93. Promega Corporation Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 94. Promega Corporation Competent Cells SWOT Analysis
Table 95. Promega Corporation Recent Development
Table 96. Beijing TransGen Biotech Company Details
Table 97. Beijing TransGen Biotech Business Overview
Table 98. Beijing TransGen Biotech Competent Cells Product and Services
Table 99. Beijing TransGen Biotech Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 100. Beijing TransGen Biotech Competent Cells SWOT Analysis
Table 101. Beijing TransGen Biotech Recent Development
Table 102. GeneScript Corporation Company Details
Table 103. GeneScript Corporation Business Overview
Table 104. GeneScript Corporation Competent Cells Product and Services
Table 105. GeneScript Corporation Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 106. GeneScript Corporation Competent Cells SWOT Analysis
Table 107. GeneScript Corporation Recent Development
Table 108. Yeastern Biotech Company Details
Table 109. Yeastern Biotech Business Overview
Table 110. Yeastern Biotech Competent Cells Product and Services
Table 111. Yeastern Biotech Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 112. Yeastern Biotech Competent Cells SWOT Analysis
Table 113. Yeastern Biotech Recent Development
Table 114. New England Biolabs Company Details
Table 115. New England Biolabs Business Overview
Table 116. New England Biolabs Competent Cells Product and Services
Table 117. New England Biolabs Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 118. New England Biolabs Competent Cells SWOT Analysis
Table 119. New England Biolabs Recent Development
Table 120. QIAGEN N.V. Company Details
Table 121. QIAGEN N.V. Business Overview
Table 122. QIAGEN N.V. Competent Cells Product and Services
Table 123. QIAGEN N.V. Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 124. QIAGEN N.V. Competent Cells SWOT Analysis
Table 125. QIAGEN N.V. Recent Development
Table 126. OriGene Technologies Company Details
Table 127. OriGene Technologies Business Overview
Table 128. OriGene Technologies Competent Cells Product and Services
Table 129. OriGene Technologies Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 130. OriGene Technologies Recent Development
Table 131. Lucigen Company Details
Table 132. Lucigen Business Overview
Table 133. Lucigen Competent Cells Product and Services
Table 134. Lucigen Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 135. Lucigen Recent Development
Table 136. Zymo Research Company Details
Table 137. Zymo Research Business Overview
Table 138. Zymo Research Competent Cells Product and Services
Table 139. Zymo Research Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 140. Zymo Research Recent Development
Table 141. Bio-Rad Laboratories Company Details
Table 142. Bio-Rad Laboratories Business Overview
Table 143. Bio-Rad Laboratories Competent Cells Product and Services
Table 144. Bio-Rad Laboratories Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 145. Bio-Rad Laboratories Recent Development
Table 146. Bioline Company Details
Table 147. Bioline Business Overview
Table 148. Bioline Competent Cells Product and Services
Table 149. Bioline Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 150. Bioline Recent Development
Table 151. Delphi Genetics Company Details
Table 152. Delphi Genetics Business Overview
Table 153. Delphi Genetics Competent Cells Product and Services
Table 154. Delphi Genetics Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 155. Delphi Genetics Recent Development
Table 156. IBA GmBH Company Details
Table 157. IBA GmBH Business Overview
Table 158. IBA GmBH Competent Cells Product and Services
Table 159. IBA GmBH Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 160. IBA GmBH Recent Development
Table 161. Cell Applications Company Details
Table 162. Cell Applications Business Overview
Table 163. Cell Applications Competent Cells Product and Services
Table 164. Cell Applications Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 165. Cell Applications Recent Development
Table 166. BioDynamics Laboratory Company Details
Table 167. BioDynamics Laboratory Business Overview
Table 168. BioDynamics Laboratory Competent Cells Product and Services
Table 169. BioDynamics Laboratory Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 170. BioDynamics Laboratory Recent Development
Table 171. Scarab Genomics Company Details
Table 172. Scarab Genomics Business Overview
Table 173. Scarab Genomics Competent Cells Product and Services
Table 174. Scarab Genomics Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 175. Scarab Genomics Recent Development
Table 176. GCC Biotech Company Details
Table 177. GCC Biotech Business Overview
Table 178. GCC Biotech Competent Cells Product and Services
Table 179. GCC Biotech Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 180. GCC Biotech Recent Development
Table 181. SMOBIO Technology Company Details
Table 182. SMOBIO Technology Business Overview
Table 183. SMOBIO Technology Competent Cells Product and Services
Table 184. SMOBIO Technology Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 185. SMOBIO Technology Recent Development
Table 186. Edge BioSystems Company Details
Table 187. Edge BioSystems Business Overview
Table 188. Edge BioSystems Competent Cells Product and Services
Table 189. Edge BioSystems Competent Cells Revenue in Competent Cells Business (2019-2024) & (US$ Million)
Table 190. Edge BioSystems Recent Development
Table 191. Competent Cells Market Trends
Table 192. Competent Cells Market Drivers
Table 193. Competent Cells Market Challenges
Table 194. Competent Cells Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Competent Cells Product Picture
Figure 2. Global Competent Cells Market Size by Type (US$ Million): 2019 VS 2023 VS 2030
Figure 3. Global Competent Cells Market Share by Type: 2023 VS 2030
Figure 4. Chemically Competent Cells Features
Figure 5. Electrocompetent Cells Features
Figure 6. Global Competent Cells Market Size by Application (US$ Million): 2019 VS 2023 VS 2030
Figure 7. Global Competent Cells Market Share by Application: 2023 VS 2030
Figure 8. Subcloning & Routine Cloning
Figure 9. Phage Display Library Construction
Figure 10. Toxic/Unstable DNA Cloning
Figure 11. High-Throughput Cloning
Figure 12. Protein Expression
Figure 13. Mutagenesis
Figure 14. Single-Stranded DNA Production
Figure 15. Bacmid Creation
Figure 16. Cre-Lox Recombination (PIR1/PIR2)
Figure 17. Competent Cells Report Years Considered
Figure 18. Global Competent Cells Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Competent Cells Market Size 2019-2030 (US$ Million)
Figure 20. Global Competent Cells Market Size Market Share by Region: 2023 VS 2030
Figure 21. Global Competent Cells Revenue Market Share by Region in 2019 VS 2023
Figure 22. Global Competent Cells Revenue Market Share Forecast by Region (2025-2030)
Figure 23. Global Top 10 Competent Cells Countries Ranking by Market Size (US$ Million) in 2023
Figure 24. Global Competent Cells Market Size of Top 10 Countries, 2019 VS 2023 VS 2030, (US$ Million)
Figure 25. Global Competent Cells Market Share by Players in 2023
Figure 26. Global Top Competent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Competent Cells as of 2023)
Figure 27. The Top 10 and 5 Players Market Share by Competent Cells Revenue in 2023
Figure 28. North America Competent Cells Revenue Market Share by Company in 2023
Figure 29. North America Competent Cells Revenue Market Share by Type (2019-2030)
Figure 30. North America Competent Cells Revenue Market Share by Application (2019-2030)
Figure 31. North America Competent Cells Revenue Share by Country (2019-2030)
Figure 32. U.S. Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 33. Canada Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 34. Europe Competent Cells Revenue Market Share by Company in 2023
Figure 35. Europe Competent Cells Revenue Market Share by Type (2019-2030)
Figure 36. Europe Competent Cells Revenue Market Share by Application (2019-2030)
Figure 37. Europe Competent Cells Revenue Share by Country (2019-2030)
Figure 38. Germany Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 39. France Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 40. U.K. Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 41. Italy Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 42. Russia Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 43. Asia Pacific Competent Cells Revenue Market Share by Company in 2023
Figure 44. Asia Pacific Competent Cells Revenue Market Share by Type (2019-2030)
Figure 45. Asia Pacific Competent Cells Revenue Market Share by Application (2019-2030)
Figure 46. Asia Pacific Competent Cells Revenue Share by Region (2019-2030)
Figure 47. China Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 48. Japan Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 49. South Korea Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 50. India Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 51. Australia Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 52. China Taiwan Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 53. Indonesia Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 54. Thailand Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 55. Malaysia Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 56. Latin America Competent Cells Revenue Market Share by Company in 2023
Figure 57. Latin America Competent Cells Revenue Market Share by Type (2019-2030)
Figure 58. Latin America Competent Cells Revenue Market Share by Application (2019-2030)
Figure 59. Latin America Competent Cells Revenue Share by Country (2019-2030)
Figure 60. Mexico Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 61. Brazil Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 62. Argentina Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 63. Middle East and Africa Competent Cells Revenue Market Share by Company in 2023
Figure 64. Middle East and Africa Competent Cells Revenue Market Share by Type (2019-2030)
Figure 65. Middle East and Africa Competent Cells Revenue Market Share by Application (2019-2030)
Figure 66. Middle East and Africa Competent Cells Revenue Share by Country (2019-2030)
Figure 67. Turkey Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 68. Saudi Arabia Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 69. UAE Competent Cells Revenue (2019-2030) & (US$ Million)
Figure 70. Merck KGaA Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 71. Thermo Fisher Scientific Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 72. Agilent Technologies Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 73. Takara Bio Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 74. Promega Corporation Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 75. Beijing TransGen Biotech Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 76. GeneScript Corporation Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 77. Yeastern Biotech Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 78. New England Biolabs Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 79. QIAGEN N.V. Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 80. OriGene Technologies Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 81. Lucigen Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 82. Zymo Research Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 83. Bio-Rad Laboratories Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 84. Bioline Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 85. Delphi Genetics Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 86. IBA GmBH Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 87. Cell Applications Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 88. BioDynamics Laboratory Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 89. Scarab Genomics Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 90. GCC Biotech Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 91. SMOBIO Technology Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 92. Edge BioSystems Revenue Growth Rate in Competent Cells Business (2019-2024)
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Competent Cells market?
The top companies in the global Competent Cells market are Merck KGaA、Thermo Fisher Scientific、Agilent Technologies.
What was the global market size of Competent Cells in 2024?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Competent Cells market size from 2024 to 2030?
What was the global market size of Competent Cells in 2030?
Related Reports
Global Competent Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Competent Cells market size was US$ 2585 million in 2025 and is forecast to reach a readjusted size of US$ 4837 million by 2032 with a CAGR of 9.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 111
USD 4250.00
(Single User License)
Global Competent Cells Market Research Report 2026
The global Competent Cells market was valued at US$ 2585 million in 2025 and is anticipated to reach US$ 4837 million by 2032, at a CAGR of 9.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 149
USD 2900.00
(Single User License)
Competent Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Competent Cells was estimated to be worth US$ 2585 million in 2025 and is projected to reach US$ 4837 million, growing at a CAGR of 9.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 144
USD 3950.00
(Single User License)
Global Competent Cells Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Competent Cells market is projected to grow from US$ 2382 million in 2024 to US$ 4456 million by 2031, at a CAGR of 9.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 173
USD 4900.00
(Single User License)
Global Competent Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Competent Cells was estimated to be worth US$ 2382 million and is forecast to reach approximately US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 166
USD 5900.00
(Single User License)
Global Competent Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Competent Cells market size was US$ 2382 million in 2024 and is forecast to a readjusted size of US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 119
USD 4250.00
(Single User License)
Competent Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Competent Cells was estimated to be worth US$ 2382 million in 2024 and is forecast to a readjusted size of US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 155
USD 3950.00
(Single User License)
Global Competent Cells Market Research Report 2025
The global market for Competent Cells was valued at US$ 2382 million in the year 2024 and is projected to reach a revised size of US$ 4456 million by 2031, growing at a CAGR of 9.5% during the forecast period.
Published Date: 2025-01-16
Pages: 110
USD 2900.00
(Single User License)
Global Competent Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Published Date: 2024-04-16
Pages: 190
USD 5900.00
(Single User License)
Global Competent Cells Market Insights, Forecast to 2030
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Published Date: 2024-04-07
Pages: 127
USD 4900.00
(Single User License)
Global Competent Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Competent Cells market size was US$ 2585 million in 2025 and is forecast to reach a readjusted size of US$ 4837 million by 2032 with a CAGR of 9.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 111
USD 4250.00 (Single User License)Global Competent Cells Market Research Report 2026
The global Competent Cells market was valued at US$ 2585 million in 2025 and is anticipated to reach US$ 4837 million by 2032, at a CAGR of 9.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 149
USD 2900.00 (Single User License)Competent Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Competent Cells was estimated to be worth US$ 2585 million in 2025 and is projected to reach US$ 4837 million, growing at a CAGR of 9.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 144
USD 3950.00 (Single User License)Global Competent Cells Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Competent Cells market is projected to grow from US$ 2382 million in 2024 to US$ 4456 million by 2031, at a CAGR of 9.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 173
USD 4900.00 (Single User License)Global Competent Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Competent Cells was estimated to be worth US$ 2382 million and is forecast to reach approximately US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 166
USD 5900.00 (Single User License)Global Competent Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Competent Cells market size was US$ 2382 million in 2024 and is forecast to a readjusted size of US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 119
USD 4250.00 (Single User License)Competent Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Competent Cells was estimated to be worth US$ 2382 million in 2024 and is forecast to a readjusted size of US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 155
USD 3950.00 (Single User License)Global Competent Cells Market Research Report 2025
The global market for Competent Cells was valued at US$ 2382 million in the year 2024 and is projected to reach a revised size of US$ 4456 million by 2031, growing at a CAGR of 9.5% during the forecast period.
Published: 2025-01-16
Pages: 110
USD 2900.00 (Single User License)Global Competent Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Published: 2024-04-16
Pages: 190
USD 5900.00 (Single User License)Global Competent Cells Market Insights, Forecast to 2030
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Published: 2024-04-07
Pages: 127
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 5600.00
USD 8400.00
USD 11200.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now